Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MED15 Mouse anti-Human, DyLight™ 550, Clone: OTI1C11, Novus Biologicals™

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP272618R

Catalog No. NBP272618R


Add to cart

Description

Description

MED15 Monoclonal specifically detects MED15 in Human samples. It is validated for Immunohistochemistry.
Specifications

Specifications

MED15
Monoclonal
DyLight 550
50mM Sodium Borate with 0.05% Sodium Azide
MED15
Recombinant protein fragment corresponding to amino acids 393-679 of human MED15 (NP_056973) produced in E.coli.
0.1 mL
51586.0
Store at 4°C in the dark.
Immunohistochemistry
OTI1C11
Immunohistochemistry
ARC105Arc105, CAG7A, CTG repeat protein 7a, CTG7A, FLJ42282, FLJ42935, mediator complex subunit 15PC2 glutamine/Q-rich-associated protein, mediator of RNA polymerase II transcription subunit 15, PC2 (positive cofactor 2, multiprotein complex) glutamine/Q-rich-associatedprotein, PC2-glutamine-rich-associated protein, PCQAPDKFZp686A2214, Positive cofactor 2 glutamine/Q-rich-associated protein, positive cofactor 2, glutamine/Q-rich-associated protein, TIG1DKFZp762B1216, TIG-1TPA-inducible gene 1 protein, TNRC7, TPA inducible gene-1, TPA inducible protein, trinucleotide repeat containing 7,105-kD, Trinucleotide repeat-containing gene 7 protein
Mouse
Affinity Purified
Primary
Human
IgG1
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit